Deerfield Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-166,666
Closed -$2.4M 169
2021
Q2
$2.4M Hold
166,666
0.04% 137
2021
Q1
$718K Hold
166,666
0.02% 130
2020
Q4
$942K Buy
+166,666
New +$672K 0.02% 127

Deerfield Management's CEREW Position: Q3 2021 in Review

Deerfield Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 166,666 shares — an estimated $2.4M sold.

Deerfield Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $2.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

  • Deerfield Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Deerfield Management sold 166,666 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $2.4M.
  • Deerfield Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
  • Deerfield Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $2.4M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.